(Q38508706)

3 September 2017

title

Induction of cell apoptosis in non-small cell lung cancer cells by cyclin A1 small interfering RNA. (English)

1 reference

3 September 2017

Nam Hoon Cho

1

1 reference

3 September 2017

Yoon Pyo Choi

2

1 reference

3 September 2017

Dong Suk Moon

3

1 reference

3 September 2017

Haeryoung Kim

4

1 reference

3 September 2017

Suki Kang

5

1 reference

3 September 2017

Owen Ding

6

1 reference

3 September 2017

Sun Young Rha

7

1 reference

3 September 2017

Yeon Ju Yang

8

1 reference

3 September 2017

Sang Ho Cho

9

1 reference

3 September 2017

publication date

1 October 2006

1 reference

3 September 2017

1 reference

3 September 2017

volume

97

1 reference

3 September 2017

issue

10

1 reference

3 September 2017

page(s)

1082-1092

1 reference

Gene expression profiling in non-small cell lung cancer: from molecular mechanisms to clinical application

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Ongoing and future trials of biologic therapies in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Perspectives for cancer therapies with cdk2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Functional siRNA expression from transfected PCR products

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

RNA-interference-based functional genomics in mammalian cells: reverse genetics coming of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

siRNA-mediated gene silencing: a global genome view

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

RNA interference: a potent tool for gene-specific therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Overexpression of B-type cyclins alters chromosomal segregation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Cell death by mitotic catastrophe: a molecular definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

21 January 2018

Cyclins and oncogenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

The cell cycle: accelerators, brakes, and checkpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

The C-terminal regulatory domain of p53 contains a functional docking site for cyclin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

p53 dephosphorylation and p21(Cip1/Waf1) translocation correlate with caspase-3 activation in TGF-beta1-induced apoptosis of HuH-7 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Increased and altered DNA binding of human p53 by S and G2/M but not Gl cyclin-dependent kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

p53-mediated cell cycle arrest and apoptosis induced by shikonin via a caspase-9-dependent mechanism in human malignant melanoma A375-S2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

Rottlerin sensitizes glioma cells to TRAIL-induced apoptosis by inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2006.00292.X

10.1111/J.1349-7006.2006.00292.X

21 January 2018

Identifiers

DOI

1 reference

3 September 2017

1 reference